1. |
Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction[J]. Scand J Surg, 2006, 95(4):260-269.
|
2. |
Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction:incidence, characteristics, and treatment strategies[J]. Gastric Cancer, 2010, 13(2):63-73.
|
3. |
Shiraishi N, Hirose P, Morimoto A, et al. Gastric tube reconstru-ction prevented esophageal reflux after proximal gastrectomy[J]. Gastric Cancer, 1998, 1(1):78-79.
|
4. |
Chen XF, Zhang B, Chen ZX, et al. Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction[J]. Dig Dis Sci, 2012, 57(3):738-745.
|
5. |
Matsui H, Igarashi N, Itano O, et al. Laparoscopic function-preserving surgery for early gastric cancer in the upper third of the stomach:vagus-sparing proximal gastrectomy with side-to-side esophagogastric-tube anastomosis[J]. Tokai J Exp Clin Med, 2007, 32(4):109-114.
|
6. |
Shiraishi N, Adachi Y, Kitano S, et al. Clinical outcome of proximal versus total gastrectomy for proximal gastric cancer[J].World J Surg, 2002, 26(9):1150-1154.
|
7. |
Wen L, Chen XZ, Wu B, et al. Total vs. proximal gastrectomy for proximal gastric cancer:a systematic review and meta-analysis[J]. Hepatogastroenterology, 2012, 59(114):633-640.
|
8. |
Barbour AP, Lagergren P, Hughes R, et al. Health-related qualityof life among patients with adenocarcinoma of the gastro-esophageal treated by gastrectomy or esophagectomy[J]. British J Surg, 2008, 95(1):80-84.
|
9. |
Washington K. 7th edition of the AJCC cancer staging manual:stomach[J]. Ann Surg Oncol, 2010, 17(12):3077-3079.
|
10. |
Deans C, Yeo MS, Soe MY, et al. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome[J]. World J Surg, 2011, 35(3):617-624.
|
11. |
Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer[J]. Surgery, 1998, 123(2):127-130.
|
12. |
An JY, Youn HG, Choi MG, et al. The difficult choice between total and proximal gastrectomy in proximal early gastric cancer[J].Am J Surg, 2008, 196(4):587-591.
|
13. |
Kaptein AA, Morita S, Sakamoto J. Quality of life in gastric cancer[J]. World J Gastroenterol, 2005, 11(21):3189-3196.
|
14. |
Takiguchi S, Yamamoto K, Hirao M, et al. A comparison of postoperative quality of life and dysfunction after Billroth Ⅰ and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer:results from a multi-institutional RCT[J]. Gastric Cancer,2012, 15(2):198-205.
|
15. |
Park SH, Cho MS, Kim YS, et al. Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy[J]. Qual Life Res, 2008, 17(2):207-214.
|
16. |
李文英, 曹淑红, 张晓峰, 等. 胃癌术后患者生活质量研究[J]. 现代预防医学, 2011, 38(21):4441-4443, 4446.
|
17. |
Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst, 1993, 85(5):365-376.
|
18. |
Blazeby JM, Conroy T, Bottomley A, et al. Clinical and psycho-metric validation of a questionnaire module, the EORTC QLQ-STO22, to assess quality of life in patients with gastric cancer[J].Eur J Cancer, 2004, 40(15):2260-2268.
|
19. |
姜宝法, 徐涛, 刘春晓, 等. 胃癌患者生活质量问卷(QLQ-STO22)中文版的制定[J]. 中国心理卫生杂志, 2005, 19(5):310-312.
|
20. |
Zhao H, Kanda K. Translation and validation of the standard Chinese version of the EORTC QLQ-C30[J]. Qual Life Res, 2000, 9(2):129-137.
|
21. |
Collard JM, Romagnoli R. Roux-en-Y jejunal loop and bile reflux[J]. Am J Surg, 2000, 179(4):298-303.
|
22. |
陈秀峰, 陈海宁, 张波, 等. Ⅱ、Ⅲ型食管胃结合部腺癌的临床分析[J]. 四川大学学报:医学版, 2012, 43(2):289-292.
|
23. |
代斌, 潘琳, 杨晨, 等. 食管胃结合部腺癌病人行近端胃与全胃切除术后生活质量比较[J]. 中国实用外科杂志, 2011, 31(2):147-149.
|
24. |
Bae JM, Kim S, Kim YW, et al. Health-related quality of life among disease-free stomach cancer survivors in Korea[J]. Qual Life Res, 2006, 15(10):1587-1596.
|
25. |
Wu CW, Chiou JM, Ko FS, et al. Quality of life after curativegastrectomy for gastric cancer in a randomised controlled trial[J].Br J Cancer, 2008, 98(1):54-59.
|